Clinical Drug Experience Knowledgebase

Arthritis, Infectious (Phase 4)

Ataxia (Phase 2)

Bacteremia (Phase 4)

Bacterial Infections (Phase 3)

Cardiac Output, Low (Phase 3)

Cerebellar Ataxia (Phase 2)

Cerebral Palsy (Phase 1)

Communicable Diseases (Phase 4)

Congenital Abnormalities (Phase 1)

Coronavirus Infections (Phase 3)

Dermatitis (Phase 4)

Dermatitis, Atopic (Phase 4)

Eczema (Phase 4)

Food Hypersensitivity (Phase 4)

Friedreich Ataxia (Phase 2)

Gram-Positive Bacterial Infections (Phase 1)

Heart Defects, Congenital (Phase 1)

Heart Diseases (Phase 2)

Hemolysis (Phase 1)

Hypersensitivity (Phase 4)

Hypoplastic Left Heart Syndrome (Phase 1)

Impetigo (Phase 4)

Infections (Phase 4)

Influenza, Human (Phase 3)

Lung Diseases (Phase 3)

Muscular Dystrophy, Facioscapulohumeral (Phase 2)

Mycobacterium Infections (Phase 3)

Neurotoxicity Syndromes (Phase 3)

Osteomyelitis (Phase 4)

Papilloma (Phase 3)

Papillomavirus Infections (Phase 4)

Pharyngitis (Phase 1)

Pneumonia (Phase 4)

Pneumonia, Pneumococcal (Phase 4)

Respiratory Tract Infections (Phase 3)

Rheumatic Diseases (Phase 2)

Rheumatic Heart Disease (Phase 2)

Rotavirus Infections (Phase 2)

Scabies (Phase 4)

Severe Acute Respiratory Syndrome (Phase 3)

Situs Inversus (Phase 3)

Streptococcal Infections (Phase 1)

Syndrome (Phase 1)

Transposition of Great Vessels (Phase 3)

Urinary Bladder Neoplasms (Phase 3)

Uterine Cervical Neoplasms (Phase 3)

Virus Diseases (Phase 3)